TWiV 1074: Clinical update with Dr. Daniel Griffin
b'
In his weekly clinical update, Dr. Griffin discusses the outcomes of SARS-CoV-2, influenza and respiratory syncytial virus infection in pediatric communities under the age of 18 years, the treatment of infants with the human monoclonal anti-respiratory syncytial virus antibody to prevent hospitalizations, most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus in the US, how the SARS-CoV-2/COVID-19 pandemic affected school attendance and child healthcare, how exposure length influenced transmission of SARS-CoV-2, how the durability of the anti-SARS-CoV-2 antibody response to protect against virus re-infection, if administration of oral antiviral therapy affected viral rebound in either the unvaccinated or vaccinated populations, as well as a reminder of the ineffectiveness of antibiotics for treating COVID-19 and the effect of vaccination on post-COVID conditions in children between 5-17 years old.
Subscribe (free):\\xa0Apple Podcasts,\\xa0Google Podcasts,\\xa0RSS,\\xa0email
Become a\\xa0patron\\xa0of\\xa0TWiV!
Links for this episode
- Pediatric\\xa0outcomes\\xa0SARS-CoV-2, flu,\\xa0RSV\\xa0(JAMA Peds.)
- SARS-CoV-2 vs\\xa0Flu\\xa0\\xa0(Wired)
- Anti-RSV\\xa0antibody treatment\\xa0for infants\\xa0(NEJM)
- Respiratory\\xa0\\xa0disease\\xa0surveillance\\xa0(CDC)
- RSV\\xa0surveillance\\xa0\\xa0(CDC)
- RSV\\xa0national trend\\xa0(CDC)
- Influenza/flu\\xa0surveillance\\xa0\\xa0(CDC)
- COVID-19\\xa0\\xa0hospital\\xa0admissions\\xa0(CDC)
- COVID-19\\xa0national trend\\xa0(CDC)
- COVID-19\\xa0wastewater\\xa0testing\\xa0(biobot)
- COVID-19 school\\xa0attendance\\xa0(JPEIDS)
- COVID-19 pandemic effects\\xa0children health\\xa0care\\xa0(JPEIDS)
- Digitally\\xa0measuring\\xa0transmission\\xa0(Nat)
- Antibody titers and\\xa0re-infection\\xa0(CMI)
- Oral antiviral and\\xa0SARS-CoV-2\\xa0rebound\\xa0(MMWR)
- Rebound after\\xa0antiviral\\xa0controlled trial\\xa0(MMWR)
- Vaccination and\\xa0antiviral therapy\\xa0(OFID)
- Antivirals and\\xa0hospitalization\\xa0(JMV)
- Antivirals\\xa0molnupiravir\\xa0(JMV)
- Convalescent plasma\\xa0and the\\xa0immunocompromised\\xa0guidelines\\xa0(IDSOciety)
- Steroid and the\\xa0cytokine\\xa0storm\\xa0(OFID)
- Anticoagulation\\xa0guidelines\\xa0(hematology.org)
- Unnecessary\\xa0antibiotics\\xa0(NEJM)
- Vaccination and\\xa0long COVID\\xa0(OFID)
- RSV\\xa0vaccination\\xa0(MMWR)
- Antivirals and\\xa0chronic kidney\\xa0disease\\xa0(CID)
- Early\\xa0administraton\\xa0of\\xa0molnupiravir\\xa0versus\\xa0ritonavir-boosted\\xa0nirmatrelvir\\xa0(Lancet)
- Contribute to our\\xa0MicrobeTV fundraiser at PWB
- Letters read\\xa0on TWiV 1074
- Dr. Griffin\\u2019s COVID treatment summary (pdf)
- Timestamps by\\xa0Jolene. Thanks!
Intro music is by\\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
'